Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsFRA:5F3 -19.61%97 PB Ratio is 3.96 as of Jul. 14, 2026, which is 44% below its 10-year median of 7.03. GuruFocus rates FRA:5F3 with a GF Score™ of 97/100 and a GF Value™ of €36.43. Among 788 Medical Devices & Instruments companies, JINS Holdings ranks worse than 76.27% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-14), JINS Holdings's share price is €32.80. JINS Holdings's Book Value per Share for the quarter that ended in Feb. 2026 was €8.28. Hence, JINS Holdings's PB Ratio of today is 3.96.
The historical rank and industry rank for JINS Holdings's PB Ratio or its related term are showing as below:
FRA:5F3'
s PB Ratio Range Over the Past 10 Years
Min: 3.15 Med: 7.03 Max: 10.96
Current: 4.08
During the past 13 years, JINS Holdings's highest PB Ratio was 10.96. The lowest was 3.15. And the median was 7.03.
FRA:5F3's PB Ratio is ranked worse than 76.27% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs FRA:5F3: 4.08
During the past 12 months, JINS Holdings's average Book Value Per Share Growth Rate was 19.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 11.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 6.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of JINS Holdings was 66.70% per year. The lowest was -2.10% per year. And the median was 12.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
JINS Holdings PB Ratio Related Terms
JINS Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for JINS Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JINS Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where JINS Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
JINS Holdings's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
JINS Holdings (FRA:5F3) has a PB Ratio of 3.96 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JINS Holdings and its competitors. This is 44% below median its historical median of 7.03. Over the past decade, JINS Holdings' PB Ratio has ranged from 3.15 to 10.96. According to the industry distribution chart, JINS Holdings ranks #601 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 76.3%.
Is JINS Holdings' PB Ratio too high?
JINS Holdings' current PB Ratio of 3.96 is 44% below median its 10-year median of 7.03. Over the past 10 years, this metric has ranged from a low of 3.15 to a high of 10.96. The Medical Devices & Instruments industry median PB Ratio is 2.05. JINS Holdings' value of 3.96 is 93.2% above this industry median. Based on the distribution chart, JINS Holdings ranks #601 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JINS Holdings has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #601 out of 788 companies for PB Ratio. This places JINS Holdings in the lower half of its industry. The industry median PB Ratio is 2.05. JINS Holdings' value of 3.96 is 93.2% above this benchmark. Historically, JINS Holdings' own PB Ratio has ranged from 3.15 to 10.96 over the past decade. While the company's 10-year median is 7.03 vs. the industry median of 2.05, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current PB Ratio of 3.96 is 93.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current PB Ratio is 3.96, which is 44% below median its own 10-year median of 7.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
JINS Holdings (FRA:5F3) has a current PB Ratio of 3.96. The stock's GF Value™ is €36.43, compared to a current price of €32.80 — trading 10% below its estimated fair value. The current PB Ratio is 3.96, which is 44% below median its 10-year median of 7.03 and 93.2% above the Medical Devices & Instruments industry median of 2.05. JINS Holdings' overall GF Score™ is 97/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For JINS Holdings (FRA:5F3), the current PB Ratio is 3.96 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (FRA:5F3) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of €32.80 is trading 10% below its estimated GF Value™ of €36.43.
Key valuation signals for FRA:5F3:
PB Ratio: 3.96 (44% below median its 10-year median of 7.03)
GF Value™: €36.43 vs. price of €32.80 (10% below fair value)
Industry Position: 93.2% above the Medical Devices & Instruments median (#601 of 788)
No single metric tells the full story. See the FRA:5F3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
97GF Score
Get the complete analysis for FRA:5F3
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5F3 has been successfully added to your 
